Patients Suffering From Emotional Dysregulation

NCT06616337 | Recruiting

• 1 other identifier: 9137
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

Emotional dysregulation (ED) is a common syndrome in psychiatric disorders. It is characterized by intense emotions, easily triggered, and with significant psychological impact: explosions of anger, irritability, impulsivity, emotional lability, etc. It is systematic in borderline personality disorder, and observed in a majority of patients with bipolar disorder. (even in the interictal period), adult ADHD, or addictions. ED is a cause of psychological distress, suicidal behavior or non-suicidal self-injury, and impaired quality of life. Pharmacological treatments only very partially improve these symptoms. Psychotherapies aimed at reducing ED are poorly developed in France. Dialectical behavioral therapy is a therapy that has shown its effectiveness in ED of BPD. This is why the psychiatry and addiction center of the University Hospitals of Strasbourg has set up groups using this psychotherapeutic approach based on this technique for almost 3 years. This technique being very little practiced in France, and even less studied, we want to see if it is adapted to a French population not accustomed to this type of practice.

Conditions

Emotional Dysregulation

Keywords

Emotional Dysregulation; Schizophrenia; Bipolar disorder; Borderline personality disorder; Attention deficit hyperactivity disorder (ADHD)

Outcome Measures

Primary Outcomes (1)

• Evaluate the change of symptoms of emotional dysregulation

  * The assessment is based on the DERS scale. Participants are asked to indicate how often the items apply to themselves, with responses ranging from 1 to 5, * The score between : * 1 means almost never (0 to 10%), * 2 means sometimes (11 to 35%), * 3 means about half the time (36 to 65%), * 4 means most of the time (66 to 90%), * 5 means almost always (91 to 100%).

  Up to 1 year

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Major subject (≥18 years old) having participated in the first session of a GREMO group, which is a behavioral and dialectical therapy protocol during the period from January 1, 2018 to December 31, 2023.

You may qualify if:

• Major subject (≥18 years old)
• Having participated in the first session of a GREMO group, which is a behavioral and dialectical therapy protocol from January 1, 2018 to December 31, 2023,
• Subject not opposing the reuse of their data for scientific research purposes.

You may not qualify if:

• Subject having expressed their opposition to the reuse of their personal data for scientific research purposes.

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Service de Psychiatrie 2 - CHU de Strasbourg - France

Strasbourg, 67091, France

RECRUITING

MeSH Terms

Conditions

Schizophrenia; Bipolar Disorder; Borderline Personality Disorder; Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic Disorders; Mental Disorders; Bipolar and Related Disorders; Mood Disorders; Personality Disorders; Attention Deficit and Disruptive Behavior Disorders; Neurodevelopmental Disorders

Central Study Contacts

Sébastien WEIBEL, MD

CONTACT

33 3 88 11 51 57; sebastien.weibel@chru-strasbourg.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 21, 2024
• First Posted: September 27, 2024
• Study Start: November 21, 2023
• Primary Completion: January 1, 2025
• Study Completion: January 21, 2025
• Last Updated: October 1, 2024

Record last verified: 2024-05

Locations

FR (1)